# Vivici

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vivici-b-v

- Industry: Food
- Headquarters: Delft, Netherlands
- Website: www.vivici.com
- Total disclosed funding: $34M
- Latest round: Series A (Feb 14, 2025)
- Investors on record: 6

## About

Founded in 2022 and based in Delft, Netherlands, Vivici BV operates as a food company that develops and produces animal-free food products like dairy protein using its precision fermentation technology. In June 2026, Vivici B.V. raised EUR 12.5 million in venture funding from European Innovation Council. As of 2023, Stephan van Sint Fiet serves as the CEO of the company. The company offers a protein source that is both healthy and ethically produced without using any animals. Precision fermentation is a process used by Vivici to produce food and drug ingredients, including enzymes and natural flavours. By using its genetic blueprints as a guide, microorganisms are instructed in this process to generate dairy proteins. The business offers smart microbes that, in regulated fermentation tanks, transform nutrients into proteins. The company will use the June 2026 funding to scale market access and supply of its precision-fermented protein portfolio, including Vivitein LF, and strengthen commercial-scale production.

## Funding rounds

- Series A, Feb 14, 2025, $34M — Fonterra Co-operative Group Limited, InnovationQuarter, APG Group NV, Invest-NL, DSM-firmenich
- Seed, Aug 14, 2023 — DSM Venturing, Fonterra Co-operative Group Limited

## Investors

- DSM Venturing (https://capitalatlas.ai/funds/dsm-venturing) — Seed
- Fonterra Co-operative Group Limited — Seed, Series A
- InnovationQuarter (https://capitalatlas.ai/funds/innovationquarter) — Series A
- APG Group NV — Series A
- Invest-NL — Series A
- DSM-firmenich — Series A